(IN BRIEF) ViiV Healthcare has received approval from China's National Medical Products Administration (NMPA) for Vocabria (cabotegravir) in combination with…
(IN BRIEF) ViiV Healthcare, a global specialist HIV company, will present 23 abstracts at the 19th Annual European AIDS Conference…
(IN BRIEF) New research led by the University of Bristol shows that countries need to improve their tracking of HIV…
LIVERPOOL, 02-Mar-2018 — /EuropaWire/ — Scientists at the University of Liverpool have identified a single genetic change in Salmonella that is…
London, UK, 23-10-2013 — /EuropaWire/ — ViiV Healthcare today announced the submission of a regulatory application in the United States for its…